Barney S. Graham

Epidemiology · 2010–2021

A researcher in the Science corpus: 40 papers; trusts 4 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 300 citations into it; #1,905 of 2,148 by trust here, #192 by citations
• Radiology, Nuclear Medicine and Imaging — 119 citations into it
• Structural Biology — 73 citations into it

Whom Barney S. Graham trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Kanekiyo
2. Zbyszek Otwinowski
3. Kevin Cowtan

Who trusts Barney S. Graham overall

1. A. Walls
2. Malik Sallam

Papers from Barney S. Graham's perspective

Ordered by how strongly the researchers Barney S. Graham trusts endorse each paper. Same corpus, a different order for every researcher.

1. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. (Annual Review of Biochemistry)
2. Structural and Functional Bases for Broad-Spectrum Neutralization of Avian and Human Influenza A Viruses (Nature Structural &Molecular Biology)
3. Phaser crystallographic software
4. Respiratory syncytial virus infection in elderly and high-risk adults. (New England Journal of Medicine)
5. Erratum: Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation
6. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. (Lancet. Infectious Diseases (Print))
7. Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
8. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus (Nature)
9. Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
10. Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes

Their papers

• Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens (2020) — 147 citations
• Next-Generation Influenza Vaccines. (2020) — 38 citations
• An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) — 2,864 citations
• Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (2020) — 974 citations
• Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (2020) — 8,213 citations
• Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization (2021) — 1,515 citations
• Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 (2021) — 631 citations
• Quadrivalent influenza nanoparticle vaccines induce broad protection (2021) — 258 citations
• Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination (2020) — 705 citations
• Next-generation influenza vaccines: opportunities and challenges (2020) — 294 citations
• A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies (2020) — 79 citations
• Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses (2020) — 50 citations
• SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness (2020) — 1,369 citations
• Animal models for COVID-19 (2020) — 803 citations
• Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation (2020) — 8,341 citations
• Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines (2020) — 30 citations
• Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (2020) — 1,289 citations
• Rapid COVID-19 vaccine development (2020) — 699 citations
• Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses (2019) — 271 citations
• Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis (2018) — 479 citations